ArticleFrontiers in immunology2022

CD33 Expression on Peripheral Blood Monocytes Predicts Efficacy of Anti-PD-1 Immunotherapy Against Non-Small Cell Lung Cancer.

Claire Olingy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.